Skip to Content

CSPC Pharmaceutical Group Ltd CHJTF

Morningstar Rating
$0.86 −0.06 (6.36%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CHJTF is trading at a 880% premium.
Price
$0.86
Fair Value
$2.40
Uncertainty
High
1-Star Price
$2.28
5-Star Price
$1.17
Economic Moat
Gzdzp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CHJTF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.92
Day Range
$0.860.86
52-Week Range
$0.640.92
Bid/Ask
$0.74 / $0.89
Market Cap
$10.25 Bil
Volume/Avg
125 / 13,471

Key Statistics

Price/Earnings (Normalized)
11.55
Price/Sales
2.30
Dividend Yield (Trailing)
4.16%
Dividend Yield (Forward)
4.16%
Total Yield
4.45%

Company Profile

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Large Value
Total Number of Employees
23,500

Competitors

Valuation

Metric
CHJTF
01177
01801
Price/Earnings (Normalized)
11.5517.02
Price/Book Value
2.191.464.87
Price/Sales
2.301.678.36
Price/Cash Flow
10.067.26
Price/Earnings
CHJTF
01177
01801

Financial Strength

Metric
CHJTF
01177
01801
Quick Ratio
2.320.902.59
Current Ratio
2.631.053.00
Interest Coverage
276.3111.55−15.20
Quick Ratio
CHJTF
01177
01801

Profitability

Metric
CHJTF
01177
01801
Return on Assets (Normalized)
14.29%4.02%−2.75%
Return on Equity (Normalized)
19.78%8.61%−5.12%
Return on Invested Capital (Normalized)
17.91%5.53%−5.63%
Return on Assets
CHJTF
01177
01801
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Eli Lilly and Co
LLY
NprkkndtXkjg$840.0 Bil
Johnson & Johnson
JNJ
WrbwkmstcVpqy$358.0 Bil
Merck & Co Inc
MRK
PbxlpfzwtWxhr$331.1 Bil
AbbVie Inc
ABBV
TjwchmnmrRppq$300.9 Bil
AstraZeneca PLC ADR
AZN
SgxpdchptKpnk$244.8 Bil
Roche Holding AG ADR
RHHBY
GmsjnccgRdcm$228.8 Bil
Novartis AG ADR
NVS
KsxkzfqvdVbrx$215.1 Bil
Amgen Inc
AMGN
CkjpkrghdBdvxd$165.3 Bil
Pfizer Inc
PFE
SkshvqvKrj$157.2 Bil
Sanofi SA ADR
SNY
RxfyjbkrlGrth$117.4 Bil

Sponsor Center